{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:18:50Z","timestamp":1781587130425,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10072-025-08345-x","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:26:14Z","timestamp":1755739574000},"page":"5305-5314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gastrointestinal symptoms are common in patients with new-onset refractory status epilepticus (NORSE)"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-7213","authenticated-orcid":false,"given":"Anima","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori J.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Riviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Muscal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Soden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Eschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"8345_CR1","doi-asserted-by":"publisher","unstructured":"Hirsch LJ et al (2018) Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection\u2010related epilepsy syndrome (FIRES), and related conditions, Epilepsia, vol. 59, no. 4, pp. 739\u2013744, Apr. https:\/\/doi.org\/10.1111\/epi.14016","DOI":"10.1111\/epi.14016"},{"key":"8345_CR2","doi-asserted-by":"publisher","unstructured":"Taraschenko O, Pavuluri S, Schmidt CM, Pulluru YR, Gupta N (Jan. 2023) Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: systematic review. Front Neurol 14:1095061. https:\/\/doi.org\/10.3389\/fneur.2023.1095061","DOI":"10.3389\/fneur.2023.1095061"},{"key":"8345_CR3","doi-asserted-by":"publisher","unstructured":"Kramer U et al (Nov. 2011) Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: A multicenter study on 77 children. Epilepsia 52(11):1956\u20131965. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03250.x","DOI":"10.1111\/j.1528-1167.2011.03250.x"},{"key":"8345_CR4","doi-asserted-by":"publisher","unstructured":"Shrestha A et al (Mar. 2023) Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with Anakinra. Front Neurol 14:1100551. https:\/\/doi.org\/10.3389\/fneur.2023.1100551","DOI":"10.3389\/fneur.2023.1100551"},{"key":"8345_CR5","doi-asserted-by":"publisher","unstructured":"Sculier C, Gaspard N (May 2019) New onset refractory status epilepticus (NORSE). Seizure 68:72\u201378. https:\/\/doi.org\/10.1016\/j.seizure.2018.09.018","DOI":"10.1016\/j.seizure.2018.09.018"},{"key":"8345_CR6","doi-asserted-by":"publisher","unstructured":"Clarkson BDS, LaFrance-Corey RG, Kahoud RJ, Farias\u2010Moeller R, Payne ET, Howe CL (2019) Functional deficiency in endogenous interleukin\u20101 receptor antagonist in patients with febrile infection\u2010related epilepsy syndrome, Annals of Neurology, vol. 85, no. 4, pp. 526\u2013537, Apr. https:\/\/doi.org\/10.1002\/ana.25439","DOI":"10.1002\/ana.25439"},{"key":"8345_CR7","doi-asserted-by":"publisher","unstructured":"Hanin A et al (Jul. 2023) Cytokines in New-Onset refractory status epilepticus predict outcomes. Ann Neurol 94(1):75\u201390. https:\/\/doi.org\/10.1002\/ana.26627","DOI":"10.1002\/ana.26627"},{"key":"8345_CR8","doi-asserted-by":"publisher","unstructured":"Gaspard N et al (2018) New-onset refractory status epilepticus (NORSE) and febrile infection\u2013related epilepsy syndrome (FIRES): State of the art and perspectives, Epilepsia, vol. 59, no. 4, pp. 745\u2013752, Apr. https:\/\/doi.org\/10.1111\/epi.14022","DOI":"10.1111\/epi.14022"},{"key":"8345_CR9","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support, Journal of Biomedical Informatics, vol. 42, no. 2, pp. 377\u2013381, Apr. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"8345_CR10","doi-asserted-by":"publisher","unstructured":"Fiser DH (Jul. 1992) Assessing the outcome of pediatric intensive care. J Pediatr 121(1):68\u201374. https:\/\/doi.org\/10.1016\/S0022-3476(05)82544-2","DOI":"10.1016\/S0022-3476(05)82544-2"},{"key":"8345_CR11","doi-asserted-by":"publisher","unstructured":"Jimenez AD et al (2024) Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis, Epilepsia, vol. 65, no. 6, Jun. https:\/\/doi.org\/10.1111\/epi.17988","DOI":"10.1111\/epi.17988"},{"key":"8345_CR12","doi-asserted-by":"publisher","unstructured":"Kazazian K et al (2025) Age-associated differences in FIRES: Characterizing prodromal presentation and long-term outcomes via the web-based NORSE\/FIRES Family Registry, Epilepsia, vol. 66, no. 3, pp. e35\u2013e40, Mar. https:\/\/doi.org\/10.1111\/epi.18260","DOI":"10.1111\/epi.18260"},{"key":"8345_CR13","doi-asserted-by":"publisher","unstructured":"Amlerova J, \u0160roubek J, Angelucci F, Hort J (May 2021) Evidences for a role of gut microbiota in pathogenesis and management of epilepsy. IJMS 22(11):5576. https:\/\/doi.org\/10.3390\/ijms22115576","DOI":"10.3390\/ijms22115576"},{"key":"8345_CR14","doi-asserted-by":"publisher","unstructured":"Jahromi SR et al (May 2011) Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. Seizure 20(4):343\u2013346. https:\/\/doi.org\/10.1016\/j.seizure.2010.12.011","DOI":"10.1016\/j.seizure.2010.12.011"},{"key":"8345_CR15","doi-asserted-by":"publisher","unstructured":"Houk AK, Harmon LA (2020) Abdominal Compartment Syndrome: A Rare Complication of Pentobarbital Treatment for New-Onset Refractory Status Epilepticus, The American Surgeon, vol. 86, no. 3, pp. 150\u2013152, Mar. https:\/\/doi.org\/10.1177\/000313482008600316","DOI":"10.1177\/000313482008600316"},{"key":"8345_CR16","doi-asserted-by":"publisher","unstructured":"Kullenberg T, L\u00f6fqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H (Aug. 2016) Long-term safety profile of Anakinra in patients with severe cryopyrin-associated periodic syndromes. Rheumatology 55(8):1499\u20131506. https:\/\/doi.org\/10.1093\/rheumatology\/kew208","DOI":"10.1093\/rheumatology\/kew208"},{"key":"8345_CR17","doi-asserted-by":"publisher","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG (Jan. 2017) Prevention and management of glucocorticoid-induced side effects: A comprehensive review. J Am Acad Dermatol 76(1):11\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239","DOI":"10.1016\/j.jaad.2016.02.1239"},{"key":"8345_CR18","doi-asserted-by":"publisher","unstructured":"Katz U, Achiron A, Sherer Y, Shoenfeld Y (2007) Safety of intravenous immunoglobulin (IVIG) therapy, Autoimmunity Reviews, vol. 6, no. 4, pp. 257\u2013259, Mar. https:\/\/doi.org\/10.1016\/j.autrev.2006.08.011","DOI":"10.1016\/j.autrev.2006.08.011"},{"issue":"5","key":"8345_CR19","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar3455","volume":"13","author":"MH Schiff","year":"2011","unstructured":"Schiff MH, Kremer JM, Jahreis A, Vernon E, Isaacs JD, Van Vollenhoven RF (2011) Integrated safety in Tocilizumab clinical trials. Arthritis Res Ther 13(5):R141. https:\/\/doi.org\/10.1186\/ar3455","journal-title":"Arthritis Res Ther"},{"key":"8345_CR20","doi-asserted-by":"publisher","unstructured":"Arya R et al (Aug. 2018) Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Epilepsy Res 144:1\u20136. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.04.012","DOI":"10.1016\/j.eplepsyres.2018.04.012"},{"key":"8345_CR21","doi-asserted-by":"publisher","unstructured":"Nabbout R et al (Oct. 2010) Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 51(10):2033\u20132037. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02703.x","DOI":"10.1111\/j.1528-1167.2010.02703.x"},{"key":"8345_CR22","doi-asserted-by":"publisher","unstructured":"Koh S, Dupuis N, Auvin S (Nov. 2020) Ketogenic diet and neuroinflammation. Epilepsy Res 167:106454. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106454","DOI":"10.1016\/j.eplepsyres.2020.106454"},{"key":"8345_CR23","doi-asserted-by":"publisher","unstructured":"Ruskin DN, Kawamura M, Masino SA (Dec. 2009) Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS ONE 4(12):e8349. https:\/\/doi.org\/10.1371\/journal.pone.0008349","DOI":"10.1371\/journal.pone.0008349"},{"key":"8345_CR24","doi-asserted-by":"publisher","unstructured":"Lee K, Kim N, Shim JO, Kim G-H (2020) Gut Bacterial Dysbiosis in Children with Intractable Epilepsy, JCM, vol. 10, no. 1, p. 5, Dec. https:\/\/doi.org\/10.3390\/jcm10010005","DOI":"10.3390\/jcm10010005"},{"key":"8345_CR25","doi-asserted-by":"publisher","unstructured":"Xie G et al (Sep. 2017) Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy. WJG 23(33):6164\u20136171. https:\/\/doi.org\/10.3748\/wjg.v23.i33.6164","DOI":"10.3748\/wjg.v23.i33.6164"},{"key":"8345_CR26","doi-asserted-by":"publisher","unstructured":"Lindefeldt M et al (Jan. 2019) The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. Npj Biofilms Microbiomes 5(1). https:\/\/doi.org\/10.1038\/s41522-018-0073-2","DOI":"10.1038\/s41522-018-0073-2"},{"key":"8345_CR27","doi-asserted-by":"publisher","unstructured":"Zhang Y-J, Li S, Gan R-Y, Zhou T, Xu D-P, Li H-B (2015) Impacts of Gut Bacteria on Human Health and Diseases, IJMS, vol. 16, no. 12, pp. 7493\u20137519, Apr. https:\/\/doi.org\/10.3390\/ijms16047493","DOI":"10.3390\/ijms16047493"},{"key":"8345_CR28","doi-asserted-by":"publisher","unstructured":"Jalanka-Tuovinen J et al (Jul. 2011) Intestinal microbiota in healthy adults: Temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 6:e23035. https:\/\/doi.org\/10.1371\/journal.pone.0023035","DOI":"10.1371\/journal.pone.0023035"},{"key":"8345_CR29","doi-asserted-by":"publisher","unstructured":"Reintam Blaser A, Starkopf J, Malbrain MLNG (2015) Abdominal signs and symptoms in intensive care patients, Anaesthesiol Intensive Ther, vol. 47, no. 4, pp. 379\u2013387, Sep. https:\/\/doi.org\/10.5603\/AIT.a2015.0022","DOI":"10.5603\/AIT.a2015.0022"},{"key":"8345_CR30","doi-asserted-by":"publisher","unstructured":"Reintam Blaser A, Jakob SM, Starkopf J (Jan. 2016) Gastrointestinal failure in the ICU. Curr Opin Crit Care 1. https:\/\/doi.org\/10.1097\/MCC.0000000000000286","DOI":"10.1097\/MCC.0000000000000286"},{"key":"8345_CR31","doi-asserted-by":"publisher","unstructured":"Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M, Hayashi M (2015) Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus, J Neurol Neurosurg Psychiatry, vol. 86, no. 7, pp. 820\u2013822, Jul. https:\/\/doi.org\/10.1136\/jnnp-2014-309388","DOI":"10.1136\/jnnp-2014-309388"},{"issue":"5","key":"8345_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4291\/wjgp.v2.i5.72","volume":"2","author":"H Akiho","year":"2011","unstructured":"Akiho H, Ihara E, Motomura Y, Nakamura K (2011) Cytokine-induced alterations of Gastrointestinal motility in Gastrointestinal disorders. WJGP 2(5):72\u201381. https:\/\/doi.org\/10.4291\/wjgp.v2.i5.72","journal-title":"WJGP"},{"key":"8345_CR33","doi-asserted-by":"publisher","unstructured":"Neurath MF (May 2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329\u2013342. https:\/\/doi.org\/10.1038\/nri3661","DOI":"10.1038\/nri3661"},{"key":"8345_CR34","doi-asserted-by":"publisher","unstructured":"Neurath MF (2024) Strategies for targeting cytokines in inflammatory bowel disease, Nat Rev Immunol, Mar. https:\/\/doi.org\/10.1038\/s41577-024-01008-6","DOI":"10.1038\/s41577-024-01008-6"},{"key":"8345_CR35","unstructured":"Cohen BH, Chinnery PF, Copeland WC POLG-Related Disorders, GeneReviews. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26471\/"},{"key":"8345_CR36","doi-asserted-by":"publisher","unstructured":"Hikmat O et al (2024) Status epilepticus in POLG disease: a large multinational study, J Neurol, vol. 271, no. 8, pp. 5156\u20135164, Aug. https:\/\/doi.org\/10.1007\/s00415-024-12463-5","DOI":"10.1007\/s00415-024-12463-5"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08345-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T03:15:09Z","timestamp":1759288509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08345-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8345"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08345-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JJR has received royalties or licenses as an editor of UpToDate, and has a spouse who is a section editor of UpToDate. JJR has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Wayne State University, Drexel University, Children\u2019s Healthcare of Atlanta, and Texas Neurological Association. EM has received consulting fees from Sobi. JS has received consulting fees from serving on the Advisory Board of Alcresta.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interests"}},{"value":"EM has participated on Data Safety Monitoring Board or Advisory Board for Methodist Hospital Houston. EM\u2019s family member has stock in Pfizer and Amgen. KE serves on the NORSE Institute Medical Science Advisory Board.The remaining authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Non-financial interests"}}]}}